Insulin Access: Modern Insulins

A Call for Modern Patient-Centered Type 1 Diabetes Treatment Guidelines

15 May 2026, 1:13 p.m. in Content Type: News & Statements, Country: Global, Insulin Access: Modern Insulins by T1International

T1International is urging the World Health Organization to include insulin analogues and insulin pens in its Type 1 Diabetes Treatment Guidelines to promote safer, more flexible, and more equitable diabetes care worldwide. The statement argues that these modern treatments improve quality of life, dosing accuracy, dignity, and health outcomes, while highlighting the inequities faced by people in low- and middle-income countries who often lack access to them. It also emphasizes the importance of including the lived experiences of people with diabetes in global healthcare policymaking to ensure treatment standards reflect both clinical evidence and real-world needs. Read more

Back to the future: When insulin access disappears

11 May 2026, 8:58 p.m. in Content Type: Advocacy Stories, Country: Hungary, Insulin Access: Modern Insulins by Kristóf Bartha

In November 2025, Novo Nordisk announced it would discontinue several insulins across Europe, including in Hungary where I’m from. For many of people, it had a significant disruption. I know this because I lived it. Read more

Voices from Gaza: Rationing Expired Insulin and No Test Strips

16 Feb 2026, 3:18 p.m. in Content Type: Advocacy Stories, Country: Palestine, Insulin Access: Modern Insulins, The Right to Full Care: Glucose Self-Monitoring Supplies by Ali Hisham and Mohammed Seyam

People living with diabetes in Gaza have suffered for years under constrained health services due to Israeli blockades. In recent years, this suffering has escalated to unimaginable levels. Insulin, diabetes supplies, and even food became almost entirely unavailable as violence intensified and entire neighbourhoods turned into battlefields.

In the last few weeks, I interviewed three people from Gaza to share their testimonies of living with type 1 diabetes there.
Read more

Fighting for Survival: The Insulin Crisis in the Democratic Republic of Congo

23 Sep 2025, 8:02 p.m. in Content Type: Advocacy Stories, Country: Democratic Republic of Congo, Insulin Access: Modern Insulins by T1International

In the Democratic Republic of Congo (DRC), living with type 1 diabetes is not only a daily challenge–it’s a fight for survival. Access to insulin is deeply unequal and increasingly precarious due to conflict, economic instability, and fragile health systems. Two members of the T1International network, Dr. Kalehezo Murhabazi Albert and Professor Justin Cikomola Cirhuza, share a glimpse into what this crisis looks like on the ground. Read more

World Health Organization Approves Rapid-Acting Insulin Analogues to the 24th EML

5 Sep 2025, 2:56 p.m. in Content Type: News & Statements, Country: Global, Insulin Access: Modern Insulins by T1International

Progress on Insulin Access: Adding Rapid-Acting Insulin Analogues to the Essential Medicines List

9 Apr 2025, 10:04 p.m. in Content Type: Advocacy Stories, Country: Global, Insulin Access: Modern Insulins by T1International

T1International Year in Review: 2024

15 Dec 2024, 11:41 a.m. in Country: Brazil, Country: Palestine, Country: United States, Insulin Access: Modern Insulins, Organizational Updates, Research, The Right to Full Care: Diabetes in Humanitarian Settings by T1International

As 2024 comes to an end, we’re taking a moment to reflect on the collective power of the T1International community. This year has been filled with challenges and victories as we’ve worked together to fight for affordable and accessible insulin. Here’s a month-by-month look at what we’ve accomplished, thanks to your support and the dedication of advocates across the globe. Read more

Make it Right: The Fight for Insulin Access on World Diabetes Day

20 Nov 2024, 6:19 p.m. in Action & Workshop, Contains: Resource, Country: South Africa, Insulin Access: Modern Insulins by Shaina Kasper

On World Diabetes Day, we shine a spotlight on a glaring injustice: millions of people with diabetes in low- and middle-income countries are denied access to affordable insulin pens—a delivery method that could save and transform lives. Pharmaceutical giants Eli Lilly, Novo Nordisk, and Sanofi have monopolized the diabetes market, prioritizing profit over people. It’s time to demand change. It’s time to make it right. Read more

World Health Organization and Novo Nordisk Foundation - A Conflict of Interest

29 May 2024, 5:43 p.m. in Content Type: News & Statements, Country: United States, Insulin Access: Modern Insulins by T1International

T1International and other organisations shared a letter today with Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, urging that the World Health Organization reject any funding directly or indirectly from the pharmaceutical industry. The entity already rejects funding from the tobacco and formula milk industry. The letter also asks WHO to push the pharmaceutical industry to lower prices and create sustainable solutions, and to practise more transparency and accountability to the global community that the entity exists to serve. Read more

Levemir Discontinuation Impacts Patients

8 Dec 2023, 1:04 p.m. in Content Type: News & Statements, Country: United States, Insulin Access: Modern Insulins

Only eight days of National Diabetes Awareness Month had passed this November when pharmaceutical company Novo Nordisk announced it would be pulling Levemir, a long-acting insulin that millions of insulin-dependent diabetic patients depend on, from the U.S. market. Read more